This suggests a comprehensive understanding of the mechanism in PD-L1 expression and its regulation in different tumour cell populations is necessary for improving current and developing future PD-1/PD-L1 based immunotherapy for these solid tumours. Here, PDCD1 is linked to neoplasm.